The GIFT Nifty futures, which is an early indicator of the Nifty50 index, were trading lower by 172 points at 22,344, indicating that the domestic benchmark indices are likely to make a negative start on Tuesday.
On Monday, 10 March, Domestic benchmark indices S&P BSE Sensex slipped by 217 points or 0.29%, and settled at 74,115 while the Nifty50 traded 0.41% lower by 92 points, settling at 22,460.
Here are some stocks that are likely to remain in focus on 11 March.
Syngene International: The company, which is a subsidiary of Biocon, has announced that it will acquire its first biologics facility in the US from Emergent Manufacturing Operations for a total consideration of $36.5 million.
Godrej Consumer Products: The company has announced the commencement of operations at its first integrated greenfield manufacturing plant in Tamil Nadu for a total investment of Rs 515 crore.
Ashoka Buildcon: The company has announced securing a LoA for a project worth Rs 311.92 crore from the Maharashtra State Electricity Transmission Co. The scope of the order is for the supply, ETC, and Civil Portion in connection with the Trunkey Works Contract for the establishment of a 400/220 KV substation at Nandgaon Peth.
Bharat Electronics: The company has announced securing orders worth Rs 843 crore since 6 March. The major orders include vessel and air traffic management systems, RF Seekers, radar upgradation, electro-optic repair facilities, spares, and services.
NTPC and NTPC Green Energy: The company, along with its subsidiary, has announced signing multiple agreements worth Rs 96,000 crore with the Chhattisgarh government.
MSTC: The company has announced securing a work order for Coal India to engage as an E-auction service provider for conducting e-auction of coal and coal products for them for a period of two years.
Emcure Pharmaceuticals: The company has announced its foray into the daily supplement space through its expansion of its Arth range. Arth offers a wide range of supplements that channel the power of ancient Indian herbs like Brahmi.
Vodafone Idea: The company has failed to provide a bank guarantee worth Rs 6,091 crore towards its shortfall in its 2015 spectrum auction dues. The Department of Telecom had instructed the company to provide a bank guarantee of Rs 6,091 crore or pay Rs 5,493 crore in Cash by 10 March.
Sun Pharma: The company has announced signing a definitive agreement to acquire Checkpoint Therapeutics for an upfront cash payment of Rs 3,099.51 crore ($355 million).
Tired of guessing stocks to trade in daily?
Unicorn Signals empowers you with powerful tools like daily stock scans for Intraday, Swing & Investing, Market Predictions and much more. Download the Unicorn Signals app today and take control of your investments!
